Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Agilent Technologies Inc.
Agilent Technologies, University of Michigan Partner on Research to Attack Prostate Cancer Using Systems Biology
April 3rd, 2009
Agilent Technologies Inc. (NYSE:A) announced its support of prostate cancer research by the University of Michigan’s Center for Translational Pathology (MCTP) through a grant of instruments and funding. The goal is to accelerate research to defeat the disease using a multidisciplinary systems biology approach. “We see this as an opportunity to partner with a truly advanced lab that is using multiple scientific disciplines to look at very important clinical problems,” said Gustavo Salem, Agilent vice president and general manager, Biological Systems Division. “This relationship will give us a better understanding of how to apply our technologies in a clinical research...
Source: Health Business Week (2009-04-03)
|
